As biotech products ripen, manufacturers ponder how best to get them to patients. Specialty pharmacy providers can help, but which is worth the money? By Wendy Diller These days, more and more biotech
A look at financing, M&A, and alliance activity in November 2000-February 2001 In this issue we are presenting another installment of our quarterly review of dealmaking—in this case November 2000-Janu